Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier"

Alzheimer's and Dementia

Volumn 5, Issue 5, 2009, Pages 433-434

  Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Activity transport; Alzheimer's disease; Blood brain barrier; Carrier medicated transport; Passive transport

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; NEUROTROPHIN;

ACTIVE IMMUNIZATION; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; DRUG DESIGN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RESEARCH; SCIENTIST;

EID: 69949165507     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2009.06.004     Document Type: Note

References (1)

1. Khachaturian Z.S., Snyder P.J., Doody R., Aisen P., Comer M., Dwyer J., et al. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement 5 (2009) 85-92